Wild-type huntingtin protects from apoptosis upstream of caspase-3

Journal of Neuroscience

Volumn 20, Issue 10, 2000, Pages 3705-3713

  Rigamonti, Dorotea ^a   Bauer, Johannes H ^b   De Fraja, Claudio ^a   Conti, Luciano ^a   Sipione, Simonetta ^a   Sciorati, Clara ^c   Clementi, Emilio ^c,d   Hackam, Abigail ^e   Hayden, Michael R ^e   Li, Yong ^b   Cooper, Jillian K ^f   Ross, Christopher A ^f   Govoni, Stefano ^g   Vincenz, Claudius ^b   Cattaneo, Elena ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF CALABRIA   (Italy)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PAVIA   (Italy)

Author keywords

CAG; Caspases; CNS cells; Huntingtin; Huntington's disease; Survival

Indexed keywords

CASPASE 3; CASPASE 9; HUNTINGTIN; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; HUNTINGTON CHOREA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRIATE CORTEX;

EID: 0034657112     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-10-03705.2000     Document Type: Article

References (42)

1. Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, Rigamonti D, Galli R, Selleri S, Di Meco F, De Fraja C, Vescovi A, Cattaneo E, Finocchiaro G (2000) Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 4:447-450.
2. Cattaneo E, Conti L (1998) Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J Neurosci Res 53:223-234.
3. Cattaneo E, Magrassi L, Santi L, Butti G, Giavazzi A, Pezzotta S (1994) A short term analysis of the behaviour of conditionally immortalized progenitors and primary neuroepithelial cells implanted into the fetal rat brain. Dev Brain Res 83:197-208.
4. Cattaneo E, De Fraja C, Conti L, Reinach B, Bolis L, Govoni S, Liboi E (1996a) Activation of the JAK-STAT pathway leads to proliferation of ST14A CNS progenitor cells. J Biol Chem 38:23374-23379.
5. Cattaneo E, Conti L, Gritti A, Frolichsthal P, Govoni S, Vescovi A (1996b) Non-virally mediated gene transfer into human Central Nervous System precursor cells. Mol Brain Res 42:161-166.
6. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P (1998) Apaf 1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94:727-737.
7. Cooper JK, Schilling G, Peters MF, Herring WJ, Sharp AH, Kaminsky Z, Masone J, Khan FA, Delanoy M, Borchelt DR, Dawson VL, Dawson TM, Ross CA (1998) Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet 7:783-790.
8. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537-548.
9. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990-1993.
10. Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, Kowall NW, Ge P, Vonsattel JP, Gusella JF, Joyner AL, MacDonald ME (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269:407-410.
11. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M, Kazemi-Esfajani P, Thornberry NA, Vaillancourt JP, Hayden MR (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 13:442-449.
12. Gorczyca W, Gong JP, Ardelt B, Traganos F, Darzynkiewicz Z (1993) The cell-cycle related differences in susceptibility of HL-60-cells to apoptosis induced by various antitumor agents. Cancer Res 53:3186-3192.
13. Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 19:2522-2534.
14. Hackam AS, Singaraja R, Wellington CL, Metzler M. McCutcheon K, Zhang T, Kalchman M, Hayden MR (1998) The influence of huntingtin protein size on nuclear localization and cellular toxicity. J Cell Biol 141:1097-1105.
15. Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li XJ, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR (1999) A YAC mouse model for Huntington's disease with full-length mutant Huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:1-20.
16. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell 72:971-983.
17. Kim M, Lee HS, LaForet G, McIntyre C, Martin EJ, Chang P, Kim TW, Williams M, Reddy PH, Tagle D, Boyce FM, Won L Heller A, Aronin N, DiFiglia M (1999) Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci 19:964-973.
18. Kim TW, Tanzi RE (1998) Neuronal intranuclear inclusions in polyglutamine diseases: nuclear weapons or nuclear fallout? Neuron 21:657-659.
19. Kowall NW, Ferrante RJ, Martin JB (1987) Pattern of cell loss in Huntington's disease. Trends Neurosci 10:24-29.
20. Lundberg C, Martinez-Serrano A, Cattaneo E, McKay RDG, Bjorklund A (1997) Survival, integration and differentiation of neural stem cell lines after transplantation to the adult rat striatum. Exp Neurol 145:342-360.
21. Lunkes A, Mandel JL (1998) A cellular model that recapitulates major pathogenic steps of Huntington's disease. Hum Mol Genet 7:1355-1361.
22. MacDonald ME, Gusella J (1996) Huntington's disease: translating a CAG repeat into a pathogenic mechanism. Curr Opin Neurobiol 6:638-643.
23. Magrassi L, Ehrlich ME, Butti G, Pezzotta S, Govoni S, Cattaneo E (1998) Basal ganglia precursors found in aggregates following embryonic transplantation adopt a striatal phenotype in heterotopic locations. Development 125:2847-2855.
24. Metzler M, Chen N, Helgason CD, Graham RK, Nichol K, McCutcheon K, Nasir J, Humphries RK, Raymond LA, Hayden MR (1999) Life without huntingtin: normal differentiation into functional neurons. J Neurochem 72:1009-1018.
25. Nasir J, Floresco SB, O'Kusky JR, Diewert VM, Richman J, Zeisler J, Borowski A, Marth JD, Phillips AG, Hayden MR (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioural and morphological changes in heterozygotes. Cell 81:811-823.
26. Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, Frey AS, Menon AS, Li XJ, Stieg PE, Yuan J, Penney JB, Young AB, Cha JH, Friedlander RM (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399:263-267.
27. O'Kusky JR, Nasir J, Cicchetti F, Parent A, Hayden MR (1999) Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene. Brain Res 818:468-479.
28. Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, Whetsell Jr WO, Miller G, Tagle DA (1998) Behavioral abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 20:198-202.
29. Reddy PH, Williams M, Tagle DA (1999) Recent advances in understanding the pathogenesis of Huntington's disease. Trends Neurosci 22:248-255.
30. Ross CA, Margolis RL, Rosenblatt A, Ranen NG, Becher MW, Aylward EA (1997) Reviews in molecular medicine: Huntington's disease and a related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine 76:305-338.
31. Sanchez I, Xu CJ, Juo P, Kakizaka A, Blenis J, Yuan J (1999) Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22:623-633.
32. Saudou F, Finkbeiner S, Devys D. Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55-66.
33. Sawa A, Wiegand GW, Cooper J, Margolis LM, Sharp AH, Lawler Jr JF, Greenamyre T, Snyder SH, Ross CA (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5: 1194-1198.
34. Sharp AH, Ross CA (1996) Neurobiology of Huntington's disease. Neurobiol Dis 3:3-15.
35. Sisodia SS (1998) Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial? Cell 95:1-4.
36. Srinivasula SM, Ahmad M, MacFarlane M, Luo Z, Fernandes-Alnemri T, Alnemri ES (1998) Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits. J Biol Chem 273:10107-10111.
37. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577.
38. Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, McCutcheon K, Salvesen GS, Propp SS, Bromm M, Rowland KJ, Zhang T, Rasper D, Roy S, Thornberry N, Pinsky L, Kakizuka A, Ross CA, Nicholson DW, Bredesen DE, Hayden MR (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273:9158-9167.
39. White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, MacDonald ME (1997) Huntingtin is required for neurogenesis and is not impaired by Huntington's disease CAG expansion. Nat Genet 17:404-410.
40. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM, Mak TW (1998) Apaf 1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94:739-750.
41. Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Esfratiadis A (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet 11:155-162.
42. Zou H, Li Y, Liu X, Wang X (1999) An APAF-1 cytochrome c multimeric complex is a functional apaptosome that activates procaspase-9. J Biol Chem 274:11549-11556.